Validity of self-testing at home with rapid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody detection by lateral flow immunoassay
BackgroundWe explore severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow immunoassay (LFIA) performance under field conditions compared to laboratory-based electrochemiluminescence immunoassay (ECLIA) and live virus neutralization.
MethodsIn July 2021, 3758 participants performed, at home, a self-administered Fortress LFIA on finger-prick blood, reported and submitted a photograph of the result, and provided a s... Expand abstract
- Publication status:
- In press
- Peer review status:
- Peer reviewed
(Version of record, pdf, 617.9KB)
- Publisher copy:
- Oxford University Press Publisher's website
- Clinical Infectious Diseases Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Deposit date:
- Copyright holder:
- Atchison et al.
- Copyright date:
- Rights statement:
- © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record